Technavio, a tech-focused market research firm, has published a new report on the global atopic dermatitis market, which is expected to grow at a CAGR of more than 4% during the forecast period, 2017-2021.
Based on geographical segmentation, Technavio market researchers categorize the global atopic dermatitis market into the following key regions: The Americas, APAC, and EMEA.
Click here to request a free sample of this report
Top three contributors for the global atopic dermatitis market are elaborated below
Atopic dermatitis drugs market in the Americas: The rising incidence of allergic conditions, such as eczema, in the region, is the major driving force behind the demand for atopic dermatitis drugs in the Americas. The market’s growth during the forecast period is anticipated to be fueled by large unmet needs in the treatment of individuals with eczema or atopic dermatitis.
According to Barath Palada, a lead analyst at Technavio, specializing in research on infectious diseases, “The market is witnessing growing vendor focus on developing new atopic dermatitis drugs for new indications such as interleukin (IL)-4, IL-5, and IL-13 and IgE. Several novel agents for the treatment of atopic dermatitis are currently in Phase II clinical trial.”
Atopic dermatitis drug market in EMEA: People suffering from conditions such as rhinitis, asthma, and atopic dermatitis and other skin disorders are the key end-users of atopic dermatitis drugs in EMEA. The anticipated rise in the prevalence of skin disorders, especially in children, during the forecast period is likely to propel the growth of the atopic dermatitis drugs market in EMEA.
Atopic dermatitis drugs market in APAC: The growth of the atopic dermatitis drugs market in APAC in the coming years is projected to be facilitated by awareness programs and collaborations. China, Malaysia, and India are some of the key revenue generating countries in the atopic dermatitis drugs market in APAC.
Ask an analyst to know more about this report
The leading vendors operating in the global atopic dermatitis drugs market are:
- LEO Pharma
- Mylan
- Valeant
- Bayer HealthCare
- Encore Dermatology
A more detailed analysis is available in the Technavio report titled, ‘Global Atopic Dermatitis Drugs Market 2017-2021’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports:
- Global Human Respiratory Syncytial Virus Drugs Market 2016-2020
- Global Multiple Myeloma Drugs Market 2017-2021
- Global Myasthenia Gravis Drugs Market 2017-2021
To read more press releases – click here
For any assistance or query, please contact our media team at:
media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
https://www.technavio.com/
